参考文献/References:
[1] 李玉林.病理学[M].8版.北京:人民卫生出版社,2013:219.
Li YL.Pathology[M].8th Ed.Beijing:People's Me-dical Publishing House,2013:219.
[2] 仁 晖,陈 红,宋俊贤,等.65岁以上老年患者血脂水平及达标率随年龄变化的趋势[J].中华老年心脑血管病杂志,2015,17(7):693-696.
Ren H,Chen H,Song JX,et al.Serum lipid level and its change withage in ≥ 65 years old patients[J].Chin J Geriatr Heart Brain Vessel Dis,2015,17(7):693-696.
[3] 陶 凌,刘 毅.Non-HDL-C:血脂干预管理的新靶标[J].临床心血管病杂志,2013,29(9):643-645.
Tao L,Liu Y.Non-HDL-C:new target for dyslipidemia management[J].Journal of Clinical Cardiology(China),2013,29(9):643-645.
[4] 陆再英,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:274-281,169-170.
Lu ZY,Zhong NS.Medicine[M].8th Ed.Beijing:People's Medical Publishing House,2013:274-281,169-170.
[5] Expert Dyslipidemia Panel of the International Athe-rosclerosis SocietyPanel Members.An international atherosclerosis society position paper:global recommendations for the management of dyslipidemia-full report[J].J Clin Lipidol,2014,8(1):29-60.
[6] Saksi J,Ijas P,Mayranpaa MI,et al.Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability[J].Circ Cardiovasc Genet,2014,7(5):588-598.
[7] Dalleywater W,Powell HA,Hubbard RB,et al.Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis:a population based study[J].Chest,2014,147(1):150-156.
[8] 王秋颖,向良浩,张伟民,等.Non-HDL-C和AI对冠心病患者病情的评估价值[J].海南医学,2015,26(13):1909-1912.
Wang QY,Xiang LH,Zhang WM,et al.Value of non-high-density lipoprotein cholesterol and atherosclerosis index for assessing the illness of patients with coronary heart disease[J].Hainan Med J,2015,26(13):1909-1912.
[9] Whelton PK, Appel LJ. Sodium and cardiovascular disease:what the datashow[J].Am J Hypertens,2014,27(9):1143-1145.
[10] 霍伊军,郝万鹏.体检人群高尿酸血症与血脂紊乱及体重指数相关性分析[J].现代检验医学杂志,2010,25(4):139-140.
Huo YJ,Hao WP.Analysis of physical examination of hyperuricemia and dyslipidemia and the correlation between body mass index[J].Journal of Modern Laboratory Medicine,2010,25(4):139-140.
[11] Morris DR,Rodriguez AJ,Moxon JV,et al.Association of lower extremityperformance with cardiovascular and all-cause mortality in patients with peripheral artery disease:a systematic review and meta-analysis[J].J Am Heart Assoc,2014,3(4):e001105.
[12] 张鹏睿,徐 援,王 广,等.非高密度脂蛋白胆固醇是评价血脂异常患者心血管风险的指标[J].首都医科大学学报,2014,35(1):73-76.
Zhang PR,Xu Y,Wang G,et al.Non-high density lipoprotein-cholesterolis an indicator to assess cardiovascular risk for subjects with dyslipidemia[J].Journal of Capital Medical University,2014,35(1):73-76.
相似文献/References:
[1]杨宏斌,黄巧平.老年心功能衰竭患者血清NT-proBNP和hs-TnT水平检测与NYHA分级的相关性分析[J].现代检验医学杂志,2019,34(02):64.[doi:10.3969/j.issn.1671-7414.2019.02.017]
YANG Hong-bin,HUANG Qiao-ping.Application of Combined Detection of Serum NT-proBNP and hs-TnT byElectrochemiluminescence in Evaluation of Elderly Patients with Heart Failure[J].Journal of Modern Laboratory Medicine,2019,34(03):64.[doi:10.3969/j.issn.1671-7414.2019.02.017]
[2]刘亚东,成 欣,李先先,等.陕西省延安市成年人群血清n-HDL-C 水平参考区间的建立及影响因素分析[J].现代检验医学杂志,2024,39(04):76.[doi:10.3969/j.issn.1671-7414.2024.04.014]
LIU Yadong,CHENG Xin,LI Xianxian,et al.Establishment of Reference Interval for Serum n-HDL-C Level of Adult Population in Yan’an City of Shaanxi Province and Analysis of Influencing Factors[J].Journal of Modern Laboratory Medicine,2024,39(03):76.[doi:10.3969/j.issn.1671-7414.2024.04.014]